Time course of oxidant markers and antioxidant defenses in subgroups of amyotrophic lateral sclerosis patients

Neurochemistry International

Volumn 56, Issue 5, 2010, Pages 687-693

  Cova, Emanuela ^a   Bongioanni, Paolo ^b   Cereda, Cristina ^a   Metelli, Maria Rita ^c   Salvaneschi, Laura ^d   Bernuzzi, Stefano ^d   Guareschi, Stefania ^a,e   Rossi, Bruno ^b   Ceroni, Mauro ^a,e  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Antioxidant defenses; Enzyme activity; Reactive oxygen species

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME ASSAY; ERYTHROCYTE; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATIENT CODING; PHENOTYPE; PRIORITY JOURNAL; TIME;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANTS; BIOLOGICAL MARKERS; DISEASE PROGRESSION; ERYTHROCYTES; FEMALE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OXIDANTS; PHENOTYPE; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 77949569546     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.02.004     Document Type: Article

References (31)

1. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat. Rev. Neurosci. 2004, 10(Suppl.):S18-S25.
2. Apostolski S., Marinkovic Z., Nikolic A., Blagojevic D., Spasic M.B., Michelson A.M. Glutathione peroxidase in amyotrophic lateral sclerosis: the effects of selenium supplementation. J. Environ. Pathol. Toxicol. Oncol. 1998, 17:325-329.
3. Babu G.N., Kumar A., Chandra R., Puri S.K., Singh R.L., Kalita J., et al. Oxidant-antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease. Neurochem. Int. 2008, 52:1284-1289.
4. Beghi E., Mennini T., Bendotti C., Bigini P., Logroscino G., Chio A., et al. The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure. Curr. Med. Chem. 2007, 14:3185-3200.
5. Bonnefont-Rousselot D., Lacomblez L., Jaudon M., Lepage S., Salachas F., Bensimon G., et al. Blood oxidative stress in amyotrophic lateral sclerosis. J. Neurol. Sci. 2000, 178:57-62.
6. Bowling A.C., Schulz J.B., Brown R.H., Beal M.F. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 1993, 61:2322-2325.
7. Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1:293-299. World Federation of Neurology Research Group on Motor Neuron Diseases.
8. Cedarbaum J.M., Stambler N. Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials. J. Neurol. Sci. 1997, 152(Suppl. 1):S1-S9.
9. Cereda C., Cova E., Di Poto C., Galli A., Mazzini G., Corato M., et al. Effect of nitric oxide on lymphocytes from sporadic amyotrophic lateral sclerosis patients: toxic or protective role?. Neurol. Sci. 2006, 27:312-316.
10. Cohen O., Kohen R., Lavon E., Abramsky O., Steiner I. Serum Cu/Zn superoxide dismutase activity is reduced in sporadic amyotrophic lateral sclerosis patients. J. Neurol. Sci. 1996, 143:118-120.
11. Cova E., Cereda C., Galli A., Curti D., Finotti C., Di Poto C., et al. Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients. Neurosci. Lett. 2006, 399:186-190.
12. Curti D., Malaspina A., Facchetti G., Camana C., Mazzini L., Tosca P., et al. Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology 1996, 47:1060-1064.
13. Ezzi S.A., Urushitani M., Julien J.P. Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J. Neurochem. 2007, 102:170-178.
14. Garofalo O., Figlewicz D.A., Thomas S.M., Butler R., Lebuis L., Rouleau G., et al. Superoxide dismutase activity in lymphoblastoid cells from motor neurone disease/amyotrophic lateral sclerosis (MND/ALS) patients. J. Neurol. Sci. 1995, 129(Suppl.):90-92.
15. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001, 18:685-716.
16. Ilzecka J. Total antioxidant status is increased in the serum of amyotrophic lateral sclerosis patients. Scand. J. Clin. Lab. Invest. 2003, 63:297-302.
17. Mates J.M., Perez-Gomez C., Nunez de Castro I. Antioxidant enzymes and human diseases. Clin. Biochem. 1999, 32:595-603.
18. Moumen R., Nouvelot A., Duval D., Lechevalier B., Viader F. Plasma superoxide dismutase and glutathione peroxidase activity in sporadic amyotrophic lateral sclerosis. J. Neurol. Sci. 1997, 151:35-39.
19. Nikolic-Kokic A., Stevic Z., Blagojevic D., Davidovic B., Jones D.R., Spasic M.B. Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients. Clin. Chem. Lab. Med.: CCLM/FESCC 2006, 44:589-593.
20. Oteiza P.I., Uchitel O.D., Carrasquedo F., Dubrovski A.L., Roma J.C., Fraga C.G. Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients. Neurochem. Res. 1997, 22:535-539.
21. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967, 70:158-169.
22. Przedborski S., Donaldson D., Jakowec M., Kish S.J., Guttman M., Rosoklija G., et al. Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis. Ann. Neurol. 1996, 39:158-165.
23. Przedborski S., Donaldson D.M., Murphy P.L., Hirsch O., Lange D., Naini A.B., et al. Blood superoxide dismutase, catalase and glutathione peroxidase activities in familial and sporadic amyotrophic lateral sclerosis. Neurodegeneration 1996, 5:57-64.
24. Re R., Pellegrini N., Proteggente A., Pannala A., Yang M., Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 1999, 26:1231-1237.
25. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
26. Said Ahmed M., Hung W.Y., Zu J.S., Hockberger P., Siddique T. Increased reactive oxygen species in familial amyotrophic lateral sclerosis with mutations in SOD1. J. Neurol. Sci. 2000, 176:88-94.
27. Siciliano G., Piazza S., Carlesi C., Del Corona A., Franzini M., Pompella A., et al. Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis. J. Neurol. 2007, 254:575-580.
28. Simpson E.P., Henry Y.K., Henkel J.S., Smith R.G., Appel S.H. Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology 2004, 62:1758-1765.
29. Tuncel D., Aydin N., Aribal Kocaturk P., Ozelci Kavas G., Sarikaya S. Red cell superoxide dismutase activity in sporadic amyotrophic lateral sclerosis. J. Clin. Neurosci. 2006, 13:991-994.
30. Urushitani M., Sik A., Sakurai T., Nukina N., Takahashi R., Julien J.P. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 2006, 9:108-118.
31. Yim M.B., Kang J.H., Yim H.S., Kwak H.S., Chock P.B., Stadtman E.R. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu, Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:5709-5714.